-
Morgan Stanley Raises Tesla's Stock Bull Case On China, Cybertruck Opportunities
2019 Dec 06, 9:35am | 433Tesla Inc (NASDAQ: TSLA) skeptics are beginning to envision a path forward for the disruptive automaker. Morgan Stanley raised its bull-case price target, asserting that Tesla is “fundamentally overvalued, but strategically undervalued.” The Rating Analysts Adam Jonas and Armintas...
-
10 Biggest Price Target Changes For Friday
2019 Dec 06, 8:11am | 349UBS lowered Ciena Corporation (NYSE: CIEN) price target from $43 to $31. Ciena shares closed at $36.29 on Thursday. Barclays cut the price target for Encana Corp (NYSE: ECA) from $11 to $5. Encana shares closed at $3.93 on Thursday. Stephens & Co. cut the price target for Michaels...
-
GrubHub Still Has Some Work To Do, Analyst Says After Deep Dive Into Food Delivery Business
2019 Dec 05, 2:30pm | 372KeyBanc analysts took a deep dive into the food delivery business and concluded industry titan GrubHub Inc (NYSE: GRUB) needs to provide evidence strategic efforts are resulting in improving trends. The Analyst KeyBanc Capital Markets analyst Andy Hargreaves maintains a Sector Weight rating on...
-
Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response
2019 Dec 05, 2:01pm | 594Biogen Inc's (NASDAQ: BIIB) presentation of aducanumab data at the Clinical Trials On Alzheimer's Disease Congress has drawn a mixed response. In late October, Biogen announced plans to revive its Alzheimer's program following a new analysis conducted by the company in consultation...
-
Street Is Bullish On Five Below After Q3 Sales Beat
2019 Dec 05, 1:00pm | 521Five Below Inc (NASDAQ: FIVE) shares are sharply higher after reporting a third-quarter sales beat on Wednesday. Five Below reported quarterly earnings of 17 cents per share, which met the analyst consensus estimate. The company reported quarterly sales of $377.4 million, which beat the analyst...
-
Aurinia Pharmaceuticals Call Buyers Hit The Jackpot With Well-Timed Option Trades
2019 Dec 05, 12:36pm | 598Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are up more than 90% on Thursday after the company reported some positive Phase 3 data on a lupus treatment drug. Voclosporin in combination with mycophenolate and low-dose corticosteroids produced significantly higher kidney response rates in...
-
Canopy Growth Is Prepared For 'Cannabis 2.0' In Canada, Analysts Say
2019 Dec 05, 12:10pm | 456Canopy Growth Inc. (NYSE: CGC) (TSE:WEED) recently announced its new product line amid Canada's "cannabis 2.0" launch this month. Here's what the sell-side thinks. The Analysts Bank of America Merrill Lynch's Christopher Carey reiterated a Buy rating on Canopy Growth and...
-
KeyBanc Downgrades Whiting Petroleum On Continued Missteps, High Leverage
2019 Dec 05, 11:21am | 316Whiting Petroleum Corp (NYSE: WLL) has exhibited poor execution over the past several quarters and has much higher financial leverage than peers, according to KeyBanc Capital Markets. The Analyst KeyBanc’s Leo Mariani downgraded Whiting Petroleum from Overweight to Sector Weight. The Thesis...
-
Bank Of America Downgrades F5 Networks, Negative Secular Trends Too Large To Ignore
2019 Dec 05, 11:14am | 363F5 Networks, Inc. (NASDAQ: FFIV) has been facing prolonged pressure on revenue growth due to the secular shift in demand from appliance-based Application Delivery Controllers (ADC) to software and cloud-based solutions, according to Bank of America Merrill Lynch. The Analyst Tal Liani downgraded F5...
-
Analysts Furnish Portfolios With RH After Beat-And-Raise Quarter
2019 Dec 05, 11:01am | 764Restoration Hardware Holdings (NYSE: RH) surged Thursday after reporting its third consecutive bottom-line beat and raise. “To management’s credit, this is becoming a common theme, as earnings have surprised to the upside multiple times this year,” Raymond James analysts...
-
Some Multi-Factor ETFs Are Really Working In 2019
2019 Dec 05, 10:27am | 447There has recently been some chatter about the go-go days of smart beta exchange traded funds winding down, but industry observers may want to be cautious when it comes to doubting multi-factor funds because some of those ETFs are delivering the goods in 2019. As has been noted, multi-factor ETFs...
-
Morgan Stanley Buys Chewy As Pet Ownership, E-Commerce Grow
2019 Dec 05, 10:20am | 465Chewy Inc (NYSE: CHWY) trades down nearly 32% year to date and 24% from its second-quarter earnings report. One analyst team sees a buying opportunity. The Rating Morgan Stanley analysts Lauren Cassel, Brian Nowak and Simeon Gutman upgraded Chewy to Overweight but cut their price target from $34 to...
-
Benzinga's Top Upgrades, Downgrades For December 5, 2019
2019 Dec 05, 10:02am | 3038Upgrades Morgan Stanley changed the rating for Brown & Brown Inc (NYSE: BRO) from Underweight to Equal-Weight. In the third quarter, Brown & Brown showed an EPS of $0.39, compared to $0.38 from the year-ago quarter. Brown & Brown's market cap stands at $10.6 billion. The stock has...
-
Sell-Side Remains Cautions On Slack Following Q3 Earnings Beat
2019 Dec 05, 10:00am | 655Slack Technologies Inc (NYSE: WORK) reported third-quarter revenue and earnings beats on Wednesday. Slack also guided for fourth-quarter revenue of between $172 million and $174 million, slightly above consensus analyst expectations of $172.4 million. However, Slack also guided for a fourth-quarter...
-
Morgan Stanley Downgrades Etsy, Anticipates Major Headwinds
2019 Dec 05, 9:48am | 420Etsy Inc (NASDAQ: ETSY) shares have yet to rebound after plunging on October’s earnings. One team of analysts isn’t hopeful for a recovery. The Rating Morgan Stanley analysts Lauren Cassel and Brian Nowak downgraded Etsy to Underweight and cut their price target from $52 to $38. The...